BioPhorum
The Gridiron Building
One Pancras Square
London
N1C 4AG
© 2019 Biophorum Operations Group · All Rights Reserved
Registered Address: 5 Westbrook Court · 2 Sharrow Vale Road · Sheffield · S11 8YZ
Company Number 06794795 · VAT Number GB298617544
Now with 19 member companies and 183 subject matter experts, the BioPhorum Cell & Gene Therapy (C>) Phorum has made great strides since its formation[...]
Read MoreWe have partnered with BioProcess International for more than five years. In that time, their conferences have provided platforms to socialize the collaboration’s key new[...]
Read MoreThe BioPhorum Cell & Gene Therapy Phorum has made significant progress since its creation in 2018 – from building networks and sharing knowledge to endorsing[...]
Read MoreBioPhorum and United States Pharmacopeia (USP) share a common direction – to accelerate biopharma innovation, quality and progress through collaboration.
Read MoreEstablished in March 2017, the Development Group’s Development Outsourcing effort aims to share and build guidance that will help companies make the best decisions and[...]
Read MoreSince its start in 2013, the Formulation Point Share has been busy. Its latest article, An inter-company perspective on biopharmaceutical drug product robustness studies, was[...]
Read MoreWe have partnered with BioProcess International for more than five years. In that time, their conferences have provided platforms to socialize the collaboration’s key new[...]
Read MoreBioPhorum’s mission has always been to make the journey for tackling industry challenges better, faster and cheaper for members. By helping you to work on[...]
Read MoreThe Fill Finish Phorum has recently embarked on a series of exciting and ambitious initiatives, exploring new technologies and processes to enhance the efficiency and[...]
Read MoreThe Advanced and Rapid Microbial Methods (ARMM) team set out a clear case for modernizing Environmental Monitoring (EM) in grade A settings: in summary bio-fluorescent[...]
Read MoreRegulators require a risk-based approach to environmental monitoring (EM)… but they give no clear definition of what “risk-based” actually means. The aim of the Environmental[...]
Read MoreThe publication of the Guidance on the use of Agile in a GxP Environment document in 2017 was well received.It described how the use of[...]
Read MoreFaster. Cheaper. Smarter. All companies are under pressure to achieve more with less, not least with their maintenance programs. But while ‘faster’ and ‘cheaper’ maintenance[...]
Read MoreBioPhorum’s mission has always been to make the journey for tackling industry challenges better, faster and cheaper for members. By helping you to work on[...]
Read MoreWe have partnered with BioProcess International for more than five years. In that time, their conferences have provided platforms to socialize the collaboration’s key new[...]
Read MoreThe relationship between suppliers and manufacturers is one of the most crucial in biopharmaceutical manufacturing. This is especially the case when forecasting and supply planning.[...]
Read MoreBioPhorum’s mission has always been to make the journey for tackling industry challenges better, faster and cheaper for members. By helping you to work on[...]
Read MoreHistorically, manufacturers have used a ‘waterfall’ approach when designing and building their production facilities, sequentially resolving and specifying all aspects up front and in detail[...]
Read MoreWe have partnered with BioProcess International for more than five years. In that time, their conferences have provided platforms to socialize the collaboration’s key new[...]
Read MoreYou use it to make change happen and that is exactly what the Phorum’s leaders did after the first edition of the Biomanufacturing Technology Roadmaps[...]
Read MoreAs the first regulatory authority in Latin America to gain full membership of the International Council for Harmonization (ICH), the Brazilian Health Regulatory Agency (Anvisa)[...]
Read MoreTo implement any change in the biopharmaceutical manufacturing industry it is important to engage with and collaborate with the regulators. Set up two years ago,[...]
Read MoreThe BioPhorum Continued Process Verification (CPV) and Informatics team has published a paper to support a risk-based approach for the validation of informatics systems for[...]
Read MoreMore than 50 per cent of biopharma products on the market now have Continued Process Verification (CPV) plans in place. Thanks to the CPV white[...]
Read MoreThis article provides a roadmap draws on the content of the CPV case study to provide a step-by-step guide in a more accessible form.
Read MoreFaster. Cheaper. Smarter. All companies are under pressure to achieve more with less, not least with their maintenance programs. But while ‘faster’ and ‘cheaper’ maintenance[...]
Read MoreThis poster presented at the BEBPA Conference, San Francisco builds and consolidates the information currently available in the industry for assessing process risk from Host[...]
Read MoreHost cell protein (HCP) constitutes a significant class of process-related impurities in biological drugs.
Read MoreThe single-use user requirements toolkit is now live and available for free download on the BioPhorum website The toolkit streamlines the design and specification process[...]
Read More